Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation
Crossref DOI link: https://doi.org/10.1007/s00262-014-1604-1
Published Online: 2014-08-28
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Wen-Juan
Liu, Xiu-Jun
Li, Liang
Li, Yi
Zhang, Sheng-Hua
Zhen, Yong-Su
Text and Data Mining valid from 2014-08-28